Use of anti-(tumour necrosis factor-α) antibody or 3-deaza-adenosine as additives to promote protection by University of Wisconsin solution in ischaemia/reperfusion injury

Clinical Science

Volumn 99, Issue 3, 2000, Pages 215-222

  Chiang, C H ^a   Wu, C P ^a   Perng, W C ^a   Yan, H C ^a   Yu, C P ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

3 Deaza adenosine; Anti (tumour necrosis factor ); Ischaemia reperfusion lung injury; University of Wisconsin solution

Indexed keywords

3 DEAZAADENOSINE; INTERCELLULAR ADHESION MOLECULE 1; PRESERVATION SOLUTION; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNIVERSITY OF WISCONSIN SOLUTION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY PERMEABILITY; CONTROLLED STUDY; HEMODYNAMICS; ISCHEMIA; LEUKOCYTE ADHERENCE INHIBITION; LUNG INJURY; LUNG PERFUSION; LUNG WEIGHT; MALE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; RAT; REPERFUSION INJURY;

EID: 0033816020     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0990215     Document Type: Article

References (47)

1. NHLBI Workshop Summary - Biology of lung preservation for transplantation
2. Increased peri-operative lung preservation injury with lung procurement by Euro Collins solution flush
3. Twenty years of lung preservation - A review
4. Lung preservation: A review of current practice and future directions
5. 72-Hour preservation of the canine pancreas
6. A clinical trial of University of Wisconsin solution for pulmonary preservation
7. Tumor necrosis factor-α in ischemia and reperfusion injury in rat lung
8. Cytokine-associated tissue injury and lethality in mice: A comparative study
9. Role of ICAM-1 in neutrophil-mediated lung vascular injury after occlusion and reperfusion
10. Requirements for tumor necrosis factor-α and interleukin-1 in limb ischemia/reperfusion injury and associated lung injury
11. Evidence for tumor necrosis factor-induced pulmonary microvascular injury after intestinal ischemia-reperfusion injury
12. Monoclonal antibody to tumor necrosis factor-alpha attenuates hemodynamic dysfunction secondary to intestinal ischemia/reperfusion in rats
13. 100 septic shock following therapy with antibody to tumor necrosis factor (TNF-α)
14. Neutrophil-endothelial cell binding in neutrophil-mediated tissue injury
15. 3-Deazaadenosine inhibits leukocyte adhesion and ICAM-1 biosynthesis in tumor necrosis factor-stimulated human endothelial cells
16. 2-cAMP as an additive to promote protection by UW solution in I/R injury
17. Protective agent used as additives in University of Wisconsin solution to promote protection against ischaemia-reperfusion injury in rat lung
18. Hypothermia and prostaglandin E1 produce synergistic attenuation of ischemia-reperfusion lung injury
19. Estimation of the filtration coefficient of pulmonary exchange vessels
20. Ischemia-reperfusion injury in the isolated rat lung: Role of flow and endogenous leukocytes
21. U-74500A inhibition of oxidant-mediated lung injury
22. Cachectin/TNF-α in septic shock and septic adult respiratory distress syndrome
23. Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in rat
24. Release of tumor necrosis factor after pulmonary artery occlusion and reperfusion
25. Cytokine interleukin-2, tumor necrosis factor alpha, and interferon-γ release after ischemia/reperfusion injury in a novel lung autograft animal model
26. Tumor necrosis factor causes increased pulmonary permeability and edema. Comparison to septic acute lung injury
27. Evidence for neutrophil-related acute lung injury after intestinal ischemia-reperfusion
28. Neutrophil kinetics and lung injury
29. Role of xanthine oxidase and neutrophils in ischemia-reperfusion injury in rabbit lung
30. Antibody against leukocyte integrin (CD18) prevents reperfusion-induced lung vascular injury
31. Mediator of ischemia-reperfusion injury of rat lung
32. Pulmonary microvascular injury following intestinal reperfusion
33. Arterial levels of oxidized glutathione (GSSG) reflect oxidant stress in vivo
34. Important component of the UW solution
35. Shock and tissue injury induced by recombinant human cachectin
36. Effects of tumor necrosis factor alpha and interleukin-1 alpha and beta on human neutrophil migration, respiratory burst and degranulation
37. Recombinant tumor necrosis factor increases pulmonary vascular permeability independent of neutrophils
38. An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin-1 and tumor necrosis factor-a increases neutrophil adherence by a CDw18-dependent mechanism
39. The action of the adenosylhomocysteine hydrolase inhibitor, 3-deazaadenosine, on phagocytic function of mouse macrophages and human monocytes
40. Inhibition of lymphocyte-mediated cytolysis by 3-deazaadenosine: Evidence for a methylation reaction essential to cytolysis
41. Regulatory role for the immune complex in modulation of phagocytosis by 3-deazaadenosine
42. 3-Deaza adenosine-induced disorganization of macrophage microfilaments
43. Inhibition of macrophage phagocytosis by methylation inhibitor: Lack of correlation of protein carboxymethylation and phospholipid methylation with phagocytosis
44. Regulation of macrophage lysosomal secretion by adenosine, adenosine phosphate esters and related structural analogues of adenosine
45. Abolishment of inhibitory effects of 3-deazaadenosine on superoxide generation of guinea pig phagocytes by pre-exposure to phorbol myristate acetate
46. Pharmacological analysis of guinea-pig macrophage chemiluminescence responses to platelet activating factor and opsonized zymosan
47. Studies concerning the mechanism of action of 3-deazaadenosine in leukocytes